BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...advancement of its four preclinical programs, and the discovery of new candidates. Glyscend raises $20.5M Glyscend Inc....
...Ventures and Huagai Capital. Targets TNF - Tumor necrosis factor BioCentury Staff NVX-CoV2373 NanoFlu Novavax Inc. Shattuck Labs Inc. ImmVira Co. Ltd. Glyscend Inc. Shukun...
Items per page:
1 - 1 of 1
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...advancement of its four preclinical programs, and the discovery of new candidates. Glyscend raises $20.5M Glyscend Inc....
...Ventures and Huagai Capital. Targets TNF - Tumor necrosis factor BioCentury Staff NVX-CoV2373 NanoFlu Novavax Inc. Shattuck Labs Inc. ImmVira Co. Ltd. Glyscend Inc. Shukun...
Items per page:
1 - 1 of 1